story of the week
Adjuvant Sunitinib Increases Disease-Free Survival in Patients With High-Risk RCC After Nephrectomy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After Nephrectomy
N. Engl. J. Med 2016 Oct 10;[EPub Ahead of Print], A Ravaud, RJ Motzer, HS Pandha, DJ George, AJ Pantuck, A Patel, YH Chang, B Escudier, F Donskov, A Magheli, G Carteni, B Laguerre, P Tomczak, J Breza, P Gerletti, M Lechuga, X Lin, JF Martini, K Ramaswamy, M Casey, M Staehler, JJ PatardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.